Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

23andMe said Monday it will lay off more than 200 employees, about 40% of its staff, and restructure the company amid its financial challenges. The genetic testing firm will discontinue the ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

The alliance positions GE Healthcare to distribute Radnet software designed to help mammography centers view images, ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

"We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," said Dr. Chris Mansi, CEO and co-founder at Viz.ai. “For many with HCM, the path to diagnosis and ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...